Do quetiapine (Seroquel) and aspirin (acetylsalicylic acid) interact to cause hematuria?

Quetiapine and Aspirin Do Not Directly Interact to Cause Hematuria

Quetiapine (Seroquel) and aspirin do not have a documented pharmacological interaction that causes hematuria. The FDA label for quetiapine does not list hematuria as an adverse effect, and there is no evidence of a direct drug-drug interaction between these two medications that would produce blood in the urine 1.

Understanding the Actual Risk: Aspirin's Independent Effect

The hematuria risk comes from aspirin alone, not from any interaction with quetiapine:

• Aspirin independently increases hematuria risk through its antiplatelet effects, with an incidence of 2.66% for gastrointestinal bleeding and increased odds ratios of 1.4-1.5 for major extracranial bleeding 2
• Among antithrombotic agents, aspirin is 6.7 times more likely to cause hematuria than clopidogrel and poses substantial bleeding risk compared to other antiplatelet agents 3
• Antiplatelet agents like aspirin are associated with visible hematuria in urological procedures, with 76.2% of hospitalized patients with gross hematuria taking anticoagulants or antiplatelet drugs 4

Quetiapine's Actual Hematologic Effects

Quetiapine has documented hematologic adverse effects, but these involve blood cell production, not bleeding:

• Leukopenia, neutropenia, and agranulocytosis are the primary hematologic concerns with quetiapine, with neutrophil counts <1.0 x 10⁹/L occurring in 0.3% of patients 1
• Thrombocytopenia has been reported in case reports, particularly when quetiapine is combined with valproic acid, but this does not directly cause hematuria 5
• The FDA label requires monitoring of complete blood counts in patients with pre-existing low white cell counts or history of drug-induced leukopenia 1

Critical Clinical Context: One Case Report Does Not Establish Causation

A single 2010 case report described epidural spinal hematoma in a patient taking warfarin, aspirin, diclofenac, and quetiapine simultaneously 6. However:

• The patient was anticoagulated with warfarin (INR 2.2-2.4), which is the primary causative agent for hemorrhage
• Multiple bleeding-risk medications were combined: warfarin + aspirin + diclofenac (NSAID), creating a well-established high-risk scenario 7, 2
• The case explicitly attributes the bleeding to "drug interaction on warfarin therapy," not to quetiapine specifically 6
• This represents a single case among multiple confounding medications, insufficient to establish quetiapine as a causative agent

Pharmacokinetic Analysis: No Mechanism for Interaction

There is no pharmacokinetic or pharmacodynamic mechanism by which quetiapine would potentiate aspirin's bleeding effects:

• Quetiapine is metabolized primarily by CYP3A4, with no documented interaction with aspirin metabolism 8
• Aspirin's metabolism involves carboxylesterases converting it to salicylic acid, a pathway unaffected by quetiapine 9
• Quetiapine does not affect platelet function, coagulation cascades, or vascular integrity in ways that would synergize with aspirin 1

Clinical Recommendation

If hematuria occurs in a patient taking both quetiapine and aspirin, attribute it to aspirin's antiplatelet effects and manage accordingly:

• Evaluate for urological pathology, as 44% of antiplatelet-associated hematuria cases have underlying urologic pathology, with 24% being malignancy 3
• Consider proton pump inhibitor prophylaxis if the patient has gastrointestinal bleeding risk factors (age ≥75 years, history of GI bleeding, concurrent NSAIDs) 2
• Do not discontinue quetiapine based on hematuria alone, as it is not the causative agent 1
• Assess whether aspirin is indicated for secondary cardiovascular prevention; if so, the benefits typically outweigh bleeding risks 2

Common Pitfall to Avoid

Do not assume that concurrent medications are interacting simply because they are prescribed together. The 2010 case report demonstrates attribution bias—multiple bleeding-risk medications were present, yet quetiapine (which lacks a bleeding mechanism) was implicated alongside the actual culprits (warfarin, aspirin, diclofenac) 6. Always evaluate each medication's independent pharmacological profile before concluding an interaction exists.